Back

Cody Doolan

Cody Doolan

Illucidx, strives to positively affect clinical and patient outcomes by providing ultra-sensitive, state-of-the-art infectious disease diagnostic tools for clinical applications. Their current focus is on creating economical near-patient malaria and COVID-19 diagnostic tests developed in low- and middle-income countries and resource-limited settings. We want to enable nucleic acid detection diagnostics to be performed anywhere without a laboratory or expensive equipment.